AdvertisementAdvertise with NZME.
Stock Takes
Stock Takes: Will NZ corporate earnings offer green shoots for the economy?
The reporting season gets fully underway next week. Will there be green shoots?
Stock Takes: Why the NZ sharemarket is lagging the rest
There are some stark contrasts between the local index and other comparable markets.
Stock Takes: F&P Healthcare rebounds, tech sector surges and what next for cannabis company?
F&P Healthcare recovers after a sell-off, and what's in store now for Cannasouth.
Stock Takes: Life in the fast lane - the auto stocks bucking NZ’s downtrend
And will new car dealership Armstrong’s try listing on the sharemarket again?
Stock Takes: Why a $4 billion deal fell over
The failed Ebos deal would have been a big bite for investors.
Stock Takes: NZ Shareholders Association on seeing the wood for the trees
The NZSA has questioned the timeliness of PGW's disclosure.
Why is there such a dearth of companies listing on the NZX?
It has been months since the last listing on the NZ Stock Exchange.
How this NZ pharma firm prices drugs to avoid villain status
This NZ drug maker says it puts health above wealth.
No easy fix for high inflation environment
Fisher Funds portfolio manager Matt Peek talks about the impact of the Budget.
Cost of Gabrielle and January floods will run into billions of dollars
Infometrics CEO Brad Olsen talks floods and reporting season.
Why the Aussie share market is looking more attractive
And Fletcher Building gets an earning's downgrade from one analyst.
Continuous Disclosure: IPO drought over and Rod Duke's latest purchase
What is happening on the markets this week.
Stock take: Death of the cinema? Plus the surprise in store for Fletcher shareholders
What's happening on the markets this week.
Continuous Disclosure: High demand for Auckland Council bond and IPO warning
Whopper debt raising from Auckland Council.
Continuous Disclosure: Why are NZ companies flocking to the ASX?
What is happening on the markets this week.
Continuous Disclosure: Port of Tauranga, fund manager fees, bank dividends
The latest on the markets.
Continuous Disclosure: Could Metlifecare deal be start of something bigger?
Once Metlife is hoovered up, the Swedes could go even further.